Phytochemicals inhibit migration of triple negative breast cancer cells by targeting kinase signaling.

Abstract:

BACKGROUND:Cell migration and invasion are essential processes for metastatic dissemination of cancer cells. Significant progress has been made in developing new therapies against oncogenic signaling to eliminate cancer cells and shrink tumors. However, inherent heterogeneity and treatment-induced adaptation to drugs commonly enable subsets of cancer cells to survive therapy. In addition to local recurrence, these cells escape a primary tumor and migrate through the stroma to access the circulation and metastasize to different organs, leading to an incurable disease. As such, therapeutics that block migration and invasion of cancer cells may inhibit or reduce metastasis and significantly improve cancer therapy. This is particularly more important for cancers, such as triple negative breast cancer, that currently lack targeted drugs. METHODS:We used cell migration, 3D invasion, zebrafish metastasis model, and phosphorylation analysis of 43 protein kinases in nine triple negative breast cancer (TNBC) cell lines to study effects of fisetin and quercetin on inhibition of TNBC cell migration, invasion, and metastasis. RESULTS:Fisetin and quercetin were highly effective against migration of all nine TNBC cell lines with up to 76 and 74% inhibitory effects, respectively. In addition, treatments significantly reduced 3D invasion of highly motile TNBC cells from spheroids into a collagen matrix and their metastasis in vivo. Fisetin and quercetin commonly targeted different components and substrates of the oncogenic PI3K/AKT pathway and significantly reduced their activities. Additionally, both compounds disrupted activities of several protein kinases in MAPK and STAT pathways. We used molecular inhibitors specific to these signaling proteins to establish the migration-inhibitory role of the two phytochemicals against TNBC cells. CONCLUSIONS:We established that fisetin and quercetin potently inhibit migration of metastatic TNBC cells by interfering with activities of oncogenic protein kinases in multiple pathways.

journal_name

BMC Cancer

journal_title

BMC cancer

authors

Shahi Thakuri P,Gupta M,Singh S,Joshi R,Glasgow E,Lekan A,Agarwal S,Luker GD,Tavana H

doi

10.1186/s12885-019-6479-2

subject

Has Abstract

pub_date

2020-01-02 00:00:00

pages

4

issue

1

issn

1471-2407

pii

10.1186/s12885-019-6479-2

journal_volume

20

pub_type

杂志文章
  • Prognostic impact of mRNA levels of osteopontin splice variants in soft tissue sarcoma patients.

    abstract:BACKGROUND:It is well known that osteopontin (OPN) plays an important role in tumor progression and that a high OPN expression level in several tumor entities correlates with poor prognosis in cancer patients. However, little is known about the prognostic relevance of the OPN mRNA splice variants. METHODS:We analyzed ...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-12-131

    authors: Hahnel A,Wichmann H,Greither T,Kappler M,Würl P,Kotzsch M,Taubert H,Vordermark D,Bache M

    更新日期:2012-04-02 00:00:00

  • Rechallenge and maintenance therapy using cetuximab and chemotherapy administered to a patient with metastatic colorectal cancer.

    abstract:BACKGROUND:Cetuximab combined with chemotherapy is one of the first-line treatments of metastatic colorectal cancer. Although disease progression inevitably occurs, rechallenge and maintenance therapies using cetuximab-based regimens may be beneficial, particularly for patients with wild-type (WT) KRAS. CASE PRESENTAT...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-017-3133-8

    authors: Ma J,Yang QL,Ling Y

    更新日期:2017-02-14 00:00:00

  • Phenotype-dependent effects of EpCAM expression on growth and invasion of human breast cancer cell lines.

    abstract:BACKGROUND:The epithelial cell adhesion molecule (EpCAM) has been shown to be overexpressed in breast cancer and stem cells and has emerged as an attractive target for immunotherapy of breast cancer patients. This study analyzes the effects of EpCAM on breast cancer cell lines with epithelial or mesenchymal phenotype. ...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-12-501

    authors: Martowicz A,Spizzo G,Gastl G,Untergasser G

    更新日期:2012-10-30 00:00:00

  • Use of non-steroidal anti-inflammatory drugs and risk of breast cancer: The Spanish Multi-Case-control (MCC) study.

    abstract:BACKGROUND:The relationship between non-steroidal anti-inflammatory drug (NSAID) consumption and breast cancer has been repeatedly studied, although the results remain controversial. Most case-control studies reported that NSAID consumption protected against breast cancer, while most cohort studies did not find this ef...

    journal_title:BMC cancer

    pub_type: 杂志文章,多中心研究

    doi:10.1186/s12885-016-2692-4

    authors: Dierssen-Sotos T,Gómez-Acebo I,de Pedro M,Pérez-Gómez B,Servitja S,Moreno V,Amiano P,Fernandez-Villa T,Barricarte A,Tardon A,Diaz-Santos M,Peiro-Perez R,Marcos-Gragera R,Lope V,Gracia-Lavedan E,Alonso MH,Michelena-Echeves

    更新日期:2016-08-20 00:00:00

  • Gene expression profile of cervical and skin tissues from human papillomavirus type 16 E6 transgenic mice.

    abstract:BACKGROUND:Although K14E6 transgenic mice develop spontaneous tumors of the skin epithelium, no spontaneous reproductive tract malignancies arise, unless the transgenic mice were treated chronically with 17beta-estradiol. These findings suggest that E6 performs critical functions in normal adult cervix and skin, highli...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-8-347

    authors: Mendoza-Villanueva D,Diaz-Chavez J,Uribe-Figueroa L,Rangel-Escareão C,Hidalgo-Miranda A,March-Mifsut S,Jimenez-Sanchez G,Lambert P,Gariglio P

    更新日期:2008-11-26 00:00:00

  • Identification of a unique hepatocellular carcinoma line, Li-7, with CD13(+) cancer stem cells hierarchy and population change upon its differentiation during culture and effects of sorafenib.

    abstract:BACKGROUNDS:Cancer stem cell (CSC) research has highlighted the necessity of developing drugs targeting CSCs. We investigated a hepatocellular carcinoma (HCC) cell line that not only has CSC hierarchy but also shows phenotypic changes (population changes) upon differentiation of CSC during culture and can be used for s...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-015-1297-7

    authors: Yamada T,Abei M,Danjoh I,Shirota R,Yamashita T,Hyodo I,Nakamura Y

    更新日期:2015-04-11 00:00:00

  • Laparoscopic versus open gastrectomy for gastric cancer, a multicenter prospectively randomized controlled trial (LOGICA-trial).

    abstract:BACKGROUND:For gastric cancer patients, surgical resection with en-bloc lymphadenectomy is the cornerstone of curative treatment. Open gastrectomy has long been the preferred surgical approach worldwide. However, this procedure is associated with considerable morbidity. Several meta-analyses have shown an advantage in ...

    journal_title:BMC cancer

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1186/s12885-015-1551-z

    authors: Haverkamp L,Brenkman HJ,Seesing MF,Gisbertz SS,van Berge Henegouwen MI,Luyer MD,Nieuwenhuijzen GA,Wijnhoven BP,van Lanschot JJ,de Steur WO,Hartgrink HH,Stoot JH,Hulsewé KW,Spillenaar Bilgen EJ,Rütter JE,Kouwenhoven EA,van

    更新日期:2015-07-29 00:00:00

  • A retrospective comparative exploratory study on two methylentetrahydrofolate reductase (MTHFR) polymorphisms in esophagogastric cancer: the A1298C MTHFR polymorphism is an independent prognostic factor only in neoadjuvantly treated gastric cancer patient

    abstract:BACKGROUND:Methylentetrahydrofolate reductase (MTHFR) plays a major role in folate metabolism and consequently could be an important factor for the efficacy of a treatment with 5-fluorouracil. Our aim was to evaluate the prognostic and predictive value of two well characterized constitutional MTHFR gene polymorphisms f...

    journal_title:BMC cancer

    pub_type: 杂志文章,多中心研究

    doi:10.1186/1471-2407-14-58

    authors: Blank S,Rachakonda S,Keller G,Weichert W,Lordick F,Langer R,Springfeld C,Bruckner T,Becker K,Kumar R,Ott K

    更新日期:2014-02-03 00:00:00

  • Analysis of the expression of Kv10.1 potassium channel in patients with brain metastases and glioblastoma multiforme: impact on survival.

    abstract:BACKGROUND:Kv10.1, a voltage-gated potassium channel only detected in the healthy brain, was found to be aberrantly expressed in extracerebral cancers. Investigations of Kv10.1 in brain metastasis and glioblastoma multiforme (GBM) are lacking. METHODS:We analyzed the expression of Kv10.1 by immunohistochemistry in the...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-015-1848-y

    authors: Martínez R,Stühmer W,Martin S,Schell J,Reichmann A,Rohde V,Pardo L

    更新日期:2015-11-03 00:00:00

  • Protein secretion in human mammary epithelial cells following HER1 receptor activation: influence of HER2 and HER3 expression.

    abstract:BACKGROUND:Protein secretion by mammary cells results in autocrine and paracrine signaling that defines cell growth, migration and the extracellular environment. Even so, we have a limited understanding of the cellular processes that regulate protein secretion. METHODS:In this study, we utilize human epithelial mammar...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-11-69

    authors: Zhang Y,Gonzalez RM,Zangar RC

    更新日期:2011-02-14 00:00:00

  • Cross-reactivity profiles of hybrid capture II, cobas, and APTIMA human papillomavirus assays: split-sample study.

    abstract:BACKGROUND:High-risk Human Papillomavirus (HPV) testing is replacing cytology in cervical cancer screening as it is more sensitive for preinvasive cervical lesions. However, the bottleneck of HPV testing is the many false positive test results (positive tests without cervical lesions). Here, we evaluated to what extent...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-016-2518-4

    authors: Preisler S,Rebolj M,Ejegod DM,Lynge E,Rygaard C,Bonde J

    更新日期:2016-07-20 00:00:00

  • Perioperative blood transfusion does not affect recurrence-free and overall survivals after curative resection for intrahepatic cholangiocarcinoma: a propensity score matching analysis.

    abstract:BACKGROUND:Whether perioperative blood transfusions (PBTs) adversely influence oncological outcomes for intrahepatic cholangiocarcinoma (ICC) patients after curative resection remains undetermined. METHODS:Of the 605 patients who underwent curative liver resection for ICC between 2000 and 2012, 93 received PBT. We con...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-017-3745-z

    authors: Zhou PY,Tang Z,Liu WR,Tian MX,Jin L,Jiang XF,Wang H,Tao CY,Ding ZB,Peng YF,Qiu SJ,Dai Z,Zhou J,Fan J,Shi YH

    更新日期:2017-11-14 00:00:00

  • Investigating the performance and cost-effectiveness of the simple ultrasound-based rules compared to the risk of malignancy index in the diagnosis of ovarian cancer (SUBSONiC-study): protocol of a prospective multicenter cohort study in the Netherlands.

    abstract:BACKGROUND:Estimating the risk of malignancy is essential in the management of adnexal masses. An accurate differential diagnosis between benign and malignant masses will reduce morbidity and costs due to unnecessary operations, and will improve referral to a gynecologic oncologist for specialized cancer care, which im...

    journal_title:BMC cancer

    pub_type: 临床试验,杂志文章,多中心研究

    doi:10.1186/s12885-015-1319-5

    authors: Meys EM,Rutten IJ,Kruitwagen RF,Slangen BF,Bergmans MG,Mertens HJ,Nolting E,Boskamp D,Beets-Tan RG,van Gorp T

    更新日期:2015-06-26 00:00:00

  • Genetic polymorphisms of RANTES, IL1-A, MCP-1 and TNF-A genes in patients with prostate cancer.

    abstract:BACKGROUND:Inflammation has been implicated as an etiological factor in several human cancers, including prostate cancer. Allelic variants of the genes involved in inflammatory pathways are logical candidates as genetic determinants of prostate cancer risk. The purpose of this study was to investigate whether single nu...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-8-382

    authors: Sáenz-López P,Carretero R,Cózar JM,Romero JM,Canton J,Vilchez JR,Tallada M,Garrido F,Ruiz-Cabello F

    更新日期:2008-12-19 00:00:00

  • Telomere length differences between colorectal polyp subtypes: a colonoscopy-based case-control study.

    abstract:BACKGROUND:Short telomeres have been associated with increased risk of many cancers, particularly cancers of the gastrointestinal tract including esophagus and stomach. However, the association between telomere length (TL) and colorectal cancer and its precursors, colorectal polyps, is not clear. METHODS:We investigat...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-018-4426-2

    authors: Hardikar S,Burnett-Hartman AN,Phipps AI,Upton MP,Zhu LC,Newcomb PA

    更新日期:2018-05-02 00:00:00

  • Racial differences in long-term adjuvant endocrine therapy adherence and mortality among Medicaid-insured breast cancer patients in Texas: Findings from TCR-Medicaid linked data.

    abstract:BACKGROUND:There are racial/ethnic disparities in breast cancer mortality may be attributed to differences in receipt of adjuvant cancer treatment. Our purpose was to determine whether the mortality disparities could be explained by racial/ethnic differences in long-term adherence to adjuvant endocrine therapy (AET). ...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-018-5121-z

    authors: Farias AJ,Wu WH,Du XL

    更新日期:2018-12-04 00:00:00

  • Ixazomib in combination with carboplatin in pretreated women with advanced triple-negative breast cancer, a phase I/II trial of the AGMT (AGMT MBC-10 trial).

    abstract:BACKGROUND:Triple-negative breast cancer (TNBC) comprises a heterogeneous group of diseases which are generally associated with poor prognosis. Up to now, no targeted treatment beyond anti-VEGF therapy has been approved for TNBC and cytotoxic agents remain the mainstay of treatment. Ixazomib is a selective and reversib...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-018-4979-0

    authors: Rinnerthaler G,Gampenrieder SP,Petzer A,Burgstaller S,Fuchs D,Rossmann D,Balic M,Egle D,Rumpold H,Singer CF,Bartsch R,Petru E,Melchardt T,Ulmer H,Mlineritsch B,Greil R

    更新日期:2018-11-06 00:00:00

  • Helicase-like transcription factor: a new marker of well-differentiated thyroid cancers.

    abstract:BACKGROUND:The preoperative characterization of thyroid nodules is a challenge for the clinicians. Fine-needle aspiration (FNA) is the commonly used pre-operative technique for diagnosis of malignant thyroid tumor. However, many benign lesions, with indeterminate diagnosis following FNA, are referred to surgery. There ...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-14-492

    authors: Arcolia V,Paci P,Dhont L,Chantrain G,Sirtaine N,Decaestecker C,Remmelink M,Belayew A,Saussez S

    更新日期:2014-07-08 00:00:00

  • A systematic review reporting quality of radiomics research in neuro-oncology: toward clinical utility and quality improvement using high-dimensional imaging features.

    abstract:BACKGROUND:To evaluate radiomics analysis in neuro-oncologic studies according to a radiomics quality score (RQS) system to find room for improvement in clinical use. METHODS:Pubmed and Embase were searched up the terms radiomics or radiogenomics and gliomas or glioblastomas until February 2019. From 189 articles, 51 ...

    journal_title:BMC cancer

    pub_type: 杂志文章,meta分析

    doi:10.1186/s12885-019-6504-5

    authors: Park JE,Kim HS,Kim D,Park SY,Kim JY,Cho SJ,Kim JH

    更新日期:2020-01-10 00:00:00

  • Phase II assessment of talabostat and cisplatin in second-line stage IV melanoma.

    abstract:BACKGROUND:Metastatic melanoma is an incurable disease with an average survival of less than one year. Talabostat is a novel dipeptidyl peptidase inhibitor with immunostimulatory properties. METHODS:This phase II, open label, single arm study was conducted to evaluate the safety and efficacy of 75-100 mg/m2 cisplatin ...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-9-263

    authors: Eager RM,Cunningham CC,Senzer NN,Stephenson J Jr,Anthony SP,O'Day SJ,Frenette G,Pavlick AC,Jones B,Uprichard M,Nemunaitis J

    更新日期:2009-07-30 00:00:00

  • Programmed cell death ligand 1 cut-point is associated with reduced disease specific survival in resected pancreatic ductal adenocarcinoma.

    abstract:BACKGROUND:Programmed cell death 1 (PD1) inhibitors have recently shown promising anti-cancer effects in a number of solid tumor types. A predictive biomarker to this class of drugs has not been clearly identified; however, overexpression of the PD1 ligand (PD-L1) has shown particular promise in lung adenocarcinoma. In...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-017-3634-5

    authors: Tessier-Cloutier B,Kalloger SE,Al-Kandari M,Milne K,Gao D,Nelson BH,Renouf DJ,Sheffield BS,Schaeffer DF

    更新日期:2017-09-05 00:00:00

  • Health profiles of 996 melanoma survivors: the M. D. Anderson experience.

    abstract:BACKGROUND:The incidence and survival of melanoma are increasing, but little is known about its long-term health effects in adult survivors. METHODS:A health survey was available from 996 melanoma survivors (577 treated with surgery alone, and 391 with combined treatments). Their medical/physiologic and psychosocial r...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-6-95

    authors: Stava C,Beck M,Weiss LT,Lopez A,Vassilopoulou-Sellin R

    更新日期:2006-04-18 00:00:00

  • Comparison of different therapeutic strategies for complete hydatidiform mole in women at least 40 years old: a retrospective cohort study.

    abstract:BACKGROUND:There are three main therapeutic strategies, namely expectant management (dilation and curettage only), prophylactic chemotherapy and prophylactic total hysterectomy for treating older women with complete hydatidiform mole (CHM). However, the scientific community has so far, not unanimously accepted the abov...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-017-3749-8

    authors: Zhao P,Chen Q,Lu W

    更新日期:2017-11-09 00:00:00

  • Topoisomerase I but not thymidylate synthase is associated with improved outcome in patients with resected colorectal cancer treated with irinotecan containing adjuvant chemotherapy.

    abstract:BACKGROUND:Thymidylate synthase (TS) and Topoisomerase I (Topo I) are significant biomarkers in colorectal cancer (CRC). We aimed to study the expression of TS and Topo I in patients with resected CRC who received adjuvant chemotherapy and correlated it with clinical outcome. METHODS:All patients diagnosed with CRC be...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-9-339

    authors: Kostopoulos I,Karavasilis V,Karina M,Bobos M,Xiros N,Pentheroudakis G,Kafiri G,Papakostas P,Vrettou E,Fountzilas G

    更新日期:2009-09-24 00:00:00

  • Sigma-2 receptor/TMEM97 agonist PB221 as an alternative drug for brain tumor.

    abstract:BACKGROUND:There are limited effective drugs that can reach the brain to target brain tumors, in particular glioblastoma, which is one of the most difficult cancers to be cured from. Because the overexpression of the sigma-2 receptor is frequently reported in glioma clinical samples and associated with poor prognosis a...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-019-5700-7

    authors: Liu CC,Yu CF,Wang SC,Li HY,Lin CM,Wang HH,Abate C,Chiang CS

    更新日期:2019-05-20 00:00:00

  • Expression of G-protein inwardly rectifying potassium channels (GIRKs) in lung cancer cell lines.

    abstract:BACKGROUND:Previous data from our laboratory has indicated that there is a functional link between the beta-adrenergic receptor signaling pathway and the G-protein inwardly rectifying potassium channel (GIRK1) in human breast cancer cell lines. We wanted to determine if GIRK channels were expressed in lung cancers and ...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-5-104

    authors: Plummer HK 3rd,Dhar MS,Cekanova M,Schuller HM

    更新日期:2005-08-18 00:00:00

  • Identification of S100A8-correlated genes for prediction of disease progression in non-muscle invasive bladder cancer.

    abstract:BACKGROUND:S100 calcium binding protein A8 (S100A8) has been implicated as a prognostic indicator in several types of cancer. However, previous studies are limited in their ability to predict the clinical behavior of the cancer. Here, we sought to identify a molecular signature based on S100A8 expression and to assess ...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-10-21

    authors: Kim SK,Kim EJ,Leem SH,Ha YS,Kim YJ,Kim WJ

    更新日期:2010-01-25 00:00:00

  • Correction to: A systematic comparison of copy number alterations in four types of female cancer.

    abstract::After publication of the original article [1] the authors found that the article contained an incorrect version of Fig. 4. This does not affect the results and conclusions of the article. ...

    journal_title:BMC cancer

    pub_type: 杂志文章,已发布勘误

    doi:10.1186/s12885-017-3766-7

    authors: Kaveh F,Baumbusch LO,Nebdal D,Børresen-Dale AL,Lingjærde OC,Edvardsen H,Kristensen VN,Solvang HK

    更新日期:2018-01-16 00:00:00

  • CD31 and VEGF are prognostic biomarkers in early-stage, but not in late-stage, laryngeal squamous cell carcinoma.

    abstract:BACKGROUND:Patients suffering from squamous cell carcinoma of the larynx (LSCC) with lymphatic metastasis have a relatively poor prognosis and often require radical therapeutic management. The mechanisms which drive metastasis to the lymph nodes are largely unknown but may be promoted by a pro-angiogenic tumor microenv...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-018-4180-5

    authors: Schlüter A,Weller P,Kanaan O,Nel I,Heusgen L,Höing B,Haßkamp P,Zander S,Mandapathil M,Dominas N,Arnolds J,Stuck BA,Lang S,Bankfalvi A,Brandau S

    更新日期:2018-03-09 00:00:00

  • The prognostic value of lncRNA SNHG1 in cancer patients: a meta-analysis.

    abstract:BACKGROUND:Increasing evidence revealed that high expression level of lncRNA SNHG1 was associated with the unfavorable prognosis of cancer and maybe used as a valuable biomarker for cancer patients. The present meta->analysis is to analyze existing data to reveal potential clinical application of SNHG1 on cancer progno...

    journal_title:BMC cancer

    pub_type: 杂志文章,meta分析

    doi:10.1186/s12885-019-5987-4

    authors: Dong B,Chen X,Zhang Y,Zhu C,Dong Q

    更新日期:2019-08-07 00:00:00